Question 1

Does Royal Bank of Canada own CLDX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Royal Bank of Canada holds 2,747 shares of CLDX (Celldex Therapeutics), worth $102,000.

Question 2

How many shares of CLDX does Royal Bank of Canada own?

Accepted Answer

As of its Q2 2026 13F, Royal Bank of Canada holds 2,747 shares of CLDX (Celldex Therapeutics).

Question 3

What is Royal Bank of Canada's CLDX position worth?

Accepted Answer

As of its Q2 2026 13F, Royal Bank of Canada's CLDX position is worth $102,000.

Question 4

Is Royal Bank of Canada buying or selling CLDX?

Accepted Answer

In Q2 2026, Royal Bank of Canada increased its CLDX position from 502 to 2,747 shares.

Question 5

When did Royal Bank of Canada first buy CLDX?

Accepted Answer

Royal Bank of Canada already held CLDX in its Q3 2019 13F, the earliest on record, and has listed it in 27 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2,747	+447.2%	$102,000	0.0%	$37.21	24
2026-Q1	Decreased	502	-78.1%	$16,000	0.0%	$31.72	0
2025-Q4	Decreased	2,292	-95.0%	$62,000	0.0%	$27.16	0
2025-Q3	Decreased	45,401	-10.3%	$1.2M	0.0%	$25.87	0
2025-Q2	Increased	50,615	+8874.3%	$1M	0.0%	$20.35	40
2025-Q1	Decreased	564	-81.4%	$10,000	0.0%	$18.15	0
2024-Q4	Decreased	3,030	-60.9%	$76,000	0.0%	$25.27	0
2024-Q3	Increased	7,753	+17.0%	$263,000	0.0%	$33.99	27